How to Buy nathbiogen Shares on Fincept?
You can buy Nath Bio-Genes (India) Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Nath Bio-Genes (India) Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Nathbiogen, including updates on board meetings and corporate actions.
Nath Bio-Genes (India) Limited - https://nathbiogenes.com
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas, pumpkin, tinda, cabbage, and French beans. It also provides crop protection supplements under the WINPro GOLii, WINall, and Win Chi Win names; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX names. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Mumbai, India.
Nath Bio-Genes (India) Limited Share Price Today
170.55
OPEN
174.00
HIGH
164.50
LOW
165.90
CLOSE
37 K
VOLUME
372 Cr
Market Cap
20637
Average Volume
Basic Materials
Sector
NSI
Exchange
Nath Bio-Genes (India) Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: NATHBIOGEN Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Nath Bio-Genes (India) Limited |
NATHBIOGEN |
INE448G01010 |
Annual General Meeting |
12 Aug 2024 |
10 |
N/A |
Nath Bio-Genes (India) Limited |
NATHBIOGEN |
INE448G01010 |
Dividend - Rs 2 Per Share |
09 Aug 2024 |
10 |
N/A |
Nath Bio-Genes (India) Limited |
NATHBIOGEN |
INE448G01010 |
Extra- Ordinary General Meeting |
07 Mar 2024 |
10 |
N/A |
Nath Bio-Genes (India) Limited |
NATHBIOGEN |
INE448G01010 |
Annual General Meeting/Dividend - Rs 2 Per Share |
04 Jul 2023 |
10 |
N/A |
Nath Bio-Genes (India) Limited |
NATHBIOGEN |
INE448G01010 |
Annual General Meeting/Dividend - Rs 2 Per Share |
23 Jun 2022 |
10 |
N/A |
NSE: NATHBIOGEN Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
NATHBIOGEN |
26 Dec 2024, 12:36:02 |
Trading Window-XBRL |
N/A |
NATHBIOGEN |
26 Dec 2024, 12:33:54 |
Trading Window |
N/A |
NATHBIOGEN |
06 Dec 2024, 16:20:58 |
Loss/Duplicate-Share Certificate-XBRL |
N/A |
NATHBIOGEN |
06 Dec 2024, 16:20:00 |
Loss of Share Certificates |
N/A |
NATHBIOGEN |
28 Nov 2024, 16:52:20 |
Loss/Duplicate-Share Certificate-XBRL |
N/A |
NSE: NATHBIOGEN Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Nath Bio-Genes (India) Limited |
NATHBIOGEN |
18 Oct 2024, 17:14:00 |
18 Oct 2024, 17:15:00 |
|
Nath Bio-Genes (India) Limited |
NATHBIOGEN |
18 Jul 2024, 17:00:00 |
18 Jul 2024, 17:00:00 |
|
Nath Bio-Genes (India) Limited |
NATHBIOGEN |
19 Apr 2024, 14:20:00 |
19 Apr 2024, 14:45:00 |
|
Nath Bio-Genes (India) Limited |
NATHBIOGEN |
06 Feb 2024, 18:00:00 |
06 Feb 2024, 18:30:00 |
|
Nath Bio-Genes (India) Limited |
NATHBIOGEN |
24 Nov 2023, 11:00:00 |
24 Nov 2023, 11:30:00 |
NSE: NATHBIOGEN Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Chairperson & Executive Director-MD |
23 Aug 1957 |
29 Mar 2000 |
00119601 |
Satish Laxminarayan Kagliwal |
Active |
Executive Director |
30 Apr 1948 |
30 May 2019 |
02057459 |
Jeevanlata Nandkishor Kagliwal |
Active |
Independent Director |
22 Jun 1974 |
01 Oct 2020 |
00243310 |
Ashu Jain |
Active |
Independent Director |
03 Jul 1958 |
07 Nov 2020 |
08863512 |
Vadla Nagbhushanam |
Active |
Independent Director |
01 Apr 1957 |
10 Feb 2021 |
07630081 |
Madhukar Dhondiraj Deshpande |
Active |
NSE: NATHBIOGEN Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
NATH BIO-GENES (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 23-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . |
NATHBIOGEN |
N/A |
INE448G01010 |
Nath Bio-Genes (India) Limited |
17 Oct 2024, 12:37:16 |
NATH BIO-GENES (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 07-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 . |
NATHBIOGEN |
N/A |
INE448G01010 |
Nath Bio-Genes (India) Limited |
30 Jul 2024, 15:23:22 |
NATH BIO-GENES (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 08-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend. |
NATHBIOGEN |
N/A |
INE448G01010 |
Nath Bio-Genes (India) Limited |
30 Apr 2024, 15:06:32 |
Financial Results/Other business matters |
NATHBIOGEN |
N/A |
INE448G01010 |
Nath Bio-Genes (India) Limited |
09 Jan 2024, 22:30:03 |
Financial Results |
NATHBIOGEN |
N/A |
INE448G01010 |
Nath Bio-Genes (India) Limited |
06 Oct 2023, 16:52:03 |
NSE: NATHBIOGEN Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results |
NATHBIOGEN |
- |
INE448G01010 |
Nath Bio-Genes (India) Limited |
17 Oct 2024, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2024 |
Financial Results |
NATHBIOGEN |
- |
INE448G01010 |
Nath Bio-Genes (India) Limited |
30 Jul 2024, 00:00:00 |
To consider and approve the financial results for the period ended Jun 30, 2024 |
Financial Results/Dividend |
NATHBIOGEN |
- |
INE448G01010 |
Nath Bio-Genes (India) Limited |
30 Apr 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 and dividend |
Financial Results/Other business matters |
NATHBIOGEN |
- |
INE448G01010 |
Nath Bio-Genes (India) Limited |
09 Jan 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
Financial Results |
NATHBIOGEN |
- |
INE448G01010 |
Nath Bio-Genes (India) Limited |
06 Oct 2023, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2023 |
NSE: NATHBIOGEN Balance Sheet Data In (Cr)
| date | period_type | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Minority Interest | Stockholders Equity | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Non Current Pension And Other Postretirement Benefit Plans | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Debt And Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Non Current Deferred Taxes Assets | Investmentin Financial Assets | Held To Maturity Securities | Available For Sale Securities | Long Term Equity Investment | Investmentsin Joint Venturesat Cost | Investmentsin Associatesat Cost | Goodwill And Other Intangible Assets | Other Intangible Assets | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Restricted Cash | Prepaid Assets | Inventory | Other Inventories | Finished Goods | Work In Process | Raw Materials | Other Receivables | Taxes Receivable | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 19,004,000.00 | 19,004,000.00 | 1,254,231,000.00 | 1,274,999,000.00 | 6,322,586,000.00 | 7,677,723,000.00 | 3,342,641,000.00 | 6,322,586,000.00 | 6,402,724,000.00 | 6,425,810,000.00 | 6,402,724,000.00 | 0.00 | 6,402,724,000.00 | 0.00 | 0.00 | 190,040,000.00 | 190,040,000.00 | 1,882,110,000.00 | 68,563,000.00 | 1,000.00 | 0.00 | 0.00 | 23,086,000.00 | 23,086,000.00 | 45,476,000.00 | 1,813,547,000.00 | 260,851,000.00 | 1,251,913,000.00 | 1,251,913,000.00 | 0.00 | 8,839,000.00 | 291,944,000.00 | 0.00 | 0.00 | 11,651,000.00 | 280,293,000.00 | 8,284,834,000.00 | 3,128,646,000.00 | 385,365,000.00 | 0.00 | 0.00 | 232,711,000.00 | 0.00 | 232,711,000.00 | 0.00 | 0.00 | 0.00 | 80,138,000.00 | 80,138,000.00 | 2,430,432,000.00 | 0.00 | 2,430,432,000.00 | 0.00 | 2,430,432,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5,156,188,000.00 | 19,577,000.00 | 0.00 | 0.00 | 1,671,421,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 51,100,000.00 | 1,477,084,000.00 | 0.00 | 0.00 | 1,937,006,000.00 | 1,916,238,000.00 | 20,768,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 19,004,000.00 | 19,004,000.00 | 329,410,000.00 | 1,103,459,000.00 | 6,011,069,000.00 | 7,202,646,000.00 | 3,092,177,000.00 | 6,011,069,000.00 | 6,099,187,000.00 | 6,147,837,000.00 | 6,099,187,000.00 | 0.00 | 6,099,187,000.00 | 4,414,745,000.00 | 1,344,225,000.00 | 190,040,000.00 | 190,040,000.00 | 2,703,119,000.00 | 78,649,000.00 | -1,000.00 | 30,000,000.00 | 0.00 | 48,650,000.00 | 48,650,000.00 | 30,000,000.00 | 2,624,470,000.00 | 86,127,000.00 | 1,054,809,000.00 | 1,054,809,000.00 | 8,839,000.00 | 8,839,000.00 | 828,743,000.00 | 383,592,000.00 | 2,716,000.00 | 9,473,000.00 | 432,962,000.00 | 8,802,306,000.00 | 3,085,659,000.00 | -1,000.00 | 12,760,000.00 | 0.00 | 535,000.00 | 0.00 | 535,000.00 | 59,928,000.00 | 0.00 | 59,928,000.00 | 88,118,000.00 | 88,118,000.00 | 2,815,172,000.00 | -175,291,000.00 | 2,990,463,000.00 | 408,828,000.00 | 41,322,000.00 | 270,574,000.00 | 48,665,000.00 | 2,221,074,000.00 | 0.00 | 5,716,647,000.00 | -2,000.00 | 50,000.00 | 1,632,297,000.00 | 2,303,091,000.00 | 0.00 | 2,179,694,000.00 | 54,291,000.00 | 69,106,000.00 | 1,741,000.00 | 62,335,000.00 | 943,086,000.00 | -70,400,000.00 | 1,013,486,000.00 | 774,049,000.00 | 1,629,393,000.00 | 774,049,000.00 | 740,100,000.00 | 33,949,000.00 |
| 2024-03-31T00:00:00 | annual | 19,004,000.00 | 19,004,000.00 | 329,410,000.00 | 1,103,459,000.00 | 6,011,069,000.00 | 7,202,646,000.00 | 3,092,177,000.00 | 6,011,069,000.00 | 6,099,187,000.00 | 6,147,837,000.00 | 6,099,187,000.00 | 0.00 | 6,099,187,000.00 | 4,414,745,000.00 | 1,344,225,000.00 | 190,040,000.00 | 190,040,000.00 | 2,703,119,000.00 | 78,649,000.00 | -1,000.00 | 30,000,000.00 | 0.00 | 48,650,000.00 | 48,650,000.00 | 30,000,000.00 | 2,624,470,000.00 | 86,127,000.00 | 1,054,809,000.00 | 1,054,809,000.00 | 8,839,000.00 | 8,839,000.00 | 828,743,000.00 | 383,592,000.00 | 2,716,000.00 | 9,473,000.00 | 432,962,000.00 | 8,802,306,000.00 | 3,085,659,000.00 | -1,000.00 | 12,760,000.00 | 0.00 | 535,000.00 | 0.00 | 535,000.00 | 59,928,000.00 | 0.00 | 59,928,000.00 | 88,118,000.00 | 88,118,000.00 | 2,815,172,000.00 | -175,291,000.00 | 2,990,463,000.00 | 408,828,000.00 | 41,322,000.00 | 270,574,000.00 | 48,665,000.00 | 2,221,074,000.00 | 0.00 | 5,716,647,000.00 | -2,000.00 | 50,000.00 | 1,632,297,000.00 | 2,303,091,000.00 | 0.00 | 2,179,694,000.00 | 54,291,000.00 | 69,106,000.00 | 1,741,000.00 | 62,335,000.00 | 943,086,000.00 | -70,400,000.00 | 1,013,486,000.00 | 774,049,000.00 | 1,629,393,000.00 | 774,049,000.00 | 740,100,000.00 | 33,949,000.00 |
| 2023-09-30T00:00:00 | quarterly | 19,004,000.00 | 19,004,000.00 | 975,852,000.00 | 1,128,117,000.00 | 5,944,457,000.00 | 7,168,568,000.00 | 3,363,064,000.00 | 5,944,457,000.00 | 6,040,451,000.00 | 6,041,688,000.00 | 6,039,891,000.00 | -560,000.00 | 6,040,451,000.00 | 0.00 | 0.00 | 190,040,000.00 | 190,040,000.00 | 2,427,637,000.00 | 33,360,000.00 | 0.00 | 0.00 | 0.00 | 1,237,000.00 | 1,237,000.00 | 32,123,000.00 | 2,394,277,000.00 | 1,071,290,000.00 | 1,126,880,000.00 | 1,126,880,000.00 | 0.00 | 8,175,000.00 | 187,932,000.00 | 0.00 | 0.00 | 1,504,000.00 | 186,428,000.00 | 8,467,528,000.00 | 2,710,187,000.00 | 226,004,000.00 | 0.00 | 0.00 | 50,488,000.00 | 0.00 | 50,488,000.00 | 0.00 | 0.00 | 0.00 | 95,994,000.00 | 95,994,000.00 | 2,337,701,000.00 | 0.00 | 2,337,701,000.00 | 0.00 | 2,337,701,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5,757,341,000.00 | 34,195,000.00 | 0.00 | 0.00 | 1,627,213,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 56,490,000.00 | 2,190,401,000.00 | 0.00 | 0.00 | 1,849,042,000.00 | 1,696,777,000.00 | 152,265,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 19,004,000.00 | 19,004,000.00 | 672,219,000.00 | 1,052,122,000.00 | 5,627,560,000.00 | 6,783,856,000.00 | 3,033,980,000.00 | 5,627,560,000.00 | 5,731,734,000.00 | 5,735,766,000.00 | 5,731,734,000.00 | -197,000.00 | 5,731,734,000.00 | 4,056,568,000.00 | 1,344,225,000.00 | 190,040,000.00 | 190,040,000.00 | 2,196,235,000.00 | 31,899,000.00 | -1,000.00 | 27,868,000.00 | 0.00 | 4,032,000.00 | 4,032,000.00 | 27,868,000.00 | 2,164,336,000.00 | 79,864,000.00 | 1,048,090,000.00 | 1,048,090,000.00 | 5,906,000.00 | 5,906,000.00 | 517,249,000.00 | 237,088,000.00 | 0.00 | 2,805,000.00 | 277,356,000.00 | 7,927,969,000.00 | 2,729,652,000.00 | 1,000.00 | 10,401,000.00 | 0.00 | 542,000.00 | 10,000.00 | 532,000.00 | 49,940,000.00 | 0.00 | 49,940,000.00 | 104,174,000.00 | 104,174,000.00 | 2,564,487,000.00 | -196,353,000.00 | 2,760,840,000.00 | 225,000,000.00 | 67,651,000.00 | 213,332,000.00 | 33,783,000.00 | 2,221,074,000.00 | 0.00 | 5,198,316,000.00 | -1,000.00 | 50,000.00 | 1,702,884,000.00 | 2,078,466,000.00 | 0.00 | 1,939,914,000.00 | 82,505,000.00 | 56,047,000.00 | 131,000.00 | 63,748,000.00 | 973,135,000.00 | -78,494,000.00 | 1,051,629,000.00 | 379,903,000.00 | 1,709,287,000.00 | 379,903,000.00 | 340,000,000.00 | 39,903,000.00 |
| 2023-03-31T00:00:00 | annual | 19,004,000.00 | 19,004,000.00 | 672,219,000.00 | 1,052,122,000.00 | 5,627,560,000.00 | 6,783,856,000.00 | 3,033,980,000.00 | 5,627,560,000.00 | 5,731,734,000.00 | 5,735,766,000.00 | 5,731,734,000.00 | -197,000.00 | 5,731,734,000.00 | 4,056,568,000.00 | 1,344,225,000.00 | 190,040,000.00 | 190,040,000.00 | 2,196,235,000.00 | 31,899,000.00 | -1,000.00 | 27,868,000.00 | 0.00 | 4,032,000.00 | 4,032,000.00 | 27,868,000.00 | 2,164,336,000.00 | 79,864,000.00 | 1,048,090,000.00 | 1,048,090,000.00 | 5,906,000.00 | 5,906,000.00 | 517,249,000.00 | 237,088,000.00 | 0.00 | 2,805,000.00 | 277,356,000.00 | 7,927,969,000.00 | 2,729,652,000.00 | 1,000.00 | 10,401,000.00 | 0.00 | 542,000.00 | 10,000.00 | 532,000.00 | 49,940,000.00 | 0.00 | 49,940,000.00 | 104,174,000.00 | 104,174,000.00 | 2,564,487,000.00 | -196,353,000.00 | 2,760,840,000.00 | 225,000,000.00 | 67,651,000.00 | 213,332,000.00 | 33,783,000.00 | 2,221,074,000.00 | 0.00 | 5,198,316,000.00 | -1,000.00 | 50,000.00 | 1,702,884,000.00 | 2,078,466,000.00 | 0.00 | 1,939,914,000.00 | 82,505,000.00 | 56,047,000.00 | 131,000.00 | 63,748,000.00 | 973,135,000.00 | -78,494,000.00 | 1,051,629,000.00 | 379,903,000.00 | 1,709,287,000.00 | 379,903,000.00 | 340,000,000.00 | 39,903,000.00 |
| 2022-03-31T00:00:00 | annual | 19,004,000.00 | 19,004,000.00 | 887,830,000.00 | 929,586,000.00 | 5,299,006,000.00 | 6,348,855,000.00 | 2,734,749,000.00 | 5,299,006,000.00 | 5,419,269,000.00 | 5,425,917,000.00 | 5,419,223,000.00 | -46,000.00 | 5,419,269,000.00 | 3,744,309,000.00 | 1,344,225,000.00 | 190,040,000.00 | 190,040,000.00 | 1,975,662,000.00 | 32,753,000.00 | -1,000.00 | 26,106,000.00 | 0.00 | 6,648,000.00 | 6,648,000.00 | 0.00 | 1,942,909,000.00 | 76,661,000.00 | 922,938,000.00 | 922,938,000.00 | 10,833,000.00 | 0.00 | 694,104,000.00 | 257,413,000.00 | 0.00 | 8,874,000.00 | 427,817,000.00 | 7,394,885,000.00 | 2,717,227,000.00 | -2,000.00 | 6,859,000.00 | 0.00 | 540,000.00 | 0.00 | 540,000.00 | 49,940,000.00 | 152,000.00 | 49,940,000.00 | 120,263,000.00 | 120,263,000.00 | 2,539,519,000.00 | -184,033,000.00 | 2,723,552,000.00 | 211,000,000.00 | 61,931,000.00 | 198,265,000.00 | 31,283,000.00 | 2,221,073,000.00 | 0.00 | 4,677,658,000.00 | 1,000.00 | 50,000.00 | 1,504,959,000.00 | 2,203,427,000.00 | 0.00 | 1,980,010,000.00 | 162,234,000.00 | 61,183,000.00 | 467,000.00 | 71,520,000.00 | 855,478,000.00 | -60,305,000.00 | 915,783,000.00 | 41,756,000.00 | 0.00 | 41,756,000.00 | 0.00 | 41,756,000.00 |
| 2021-03-31T00:00:00 | annual | 19,004,000.00 | 19,004,000.00 | 915,677,000.00 | 1,007,788,000.00 | 5,996,601,000.00 | 7,140,577,000.00 | 3,630,977,000.00 | 5,996,601,000.00 | 6,132,789,000.00 | 6,139,317,000.00 | 6,132,789,000.00 | 0.00 | 6,132,789,000.00 | 4,456,123,000.00 | 1,344,225,000.00 | 190,040,000.00 | 190,040,000.00 | 1,762,311,000.00 | 32,273,000.00 | -1,000.00 | 25,746,000.00 | 0.00 | 6,528,000.00 | 6,528,000.00 | 25,746,000.00 | 1,730,038,000.00 | 78,243,000.00 | 1,001,260,000.00 | 1,001,260,000.00 | 4,934,000.00 | 4,934,000.00 | 425,239,000.00 | 48,976,000.00 | 0.00 | 25,311,000.00 | 350,952,000.00 | 7,895,100,000.00 | 2,534,085,000.00 | 1,000.00 | 2,350,000.00 | 0.00 | 538,000.00 | 0.00 | 538,000.00 | 49,940,000.00 | 0.00 | 49,940,000.00 | 136,188,000.00 | 136,188,000.00 | 2,344,960,000.00 | -179,606,000.00 | 2,524,566,000.00 | 12,000,000.00 | 59,564,000.00 | 200,907,000.00 | 31,022,000.00 | 2,221,073,000.00 | 0.00 | 5,361,015,000.00 | -1,000.00 | 200,050,000.00 | 1,610,208,000.00 | 2,262,999,000.00 | 0.00 | 2,136,365,000.00 | 55,743,000.00 | 70,891,000.00 | 336,000.00 | 101,385,000.00 | 1,093,927,000.00 | -32,081,000.00 | 1,126,008,000.00 | 92,111,000.00 | 0.00 | 92,111,000.00 | 200,050,000.00 | 92,111,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 68,592,981.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: NATHBIOGEN Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Capital Expenditure | End Cash Position | Other Cash Adjustment Outside Changein Cash | Beginning Cash Position | Changes In Cash | Financing Cash Flow | Net Other Financing Charges | Interest Paid Cff | Cash Dividends Paid | Net Issuance Payments Of Debt | Net Short Term Debt Issuance | Net Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Net Investment Purchase And Sale | Purchase Of Investment | Net Intangibles Purchase And Sale | Sale Of Intangibles | Purchase Of Intangibles | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Capital Expenditure Reported | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Liabilities | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Pension And Employee Benefit Expense | Gain Loss On Sale Of PPE | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 478,181,000.00 | -267,756,000.00 | 774,099,000.00 | 1,000.00 | 379,952,000.00 | 394,146,000.00 | -77,780,000.00 | -1,000.00 | -91,112,000.00 | -38,008,000.00 | 51,341,000.00 | 27,103,000.00 | 24,238,000.00 | -274,011,000.00 | 1,000.00 | 3,224,000.00 | -9,980,000.00 | -9,980,000.00 | 0.00 | 0.00 | 0.00 | -267,255,000.00 | 501,000.00 | -267,756,000.00 | 0.00 | 745,937,000.00 | -3,403,000.00 | 230,948,000.00 | 288,208,000.00 | -11,254,000.00 | 155,606,000.00 | -224,625,000.00 | 23,014,000.00 | 97,165,000.00 | -32,086,000.00 | 32,612,000.00 | 16,056,000.00 | 16,556,000.00 | 5,065,000.00 | -10,000.00 | 415,647,000.00 |
| 2023-03-31T00:00:00 | annual | 358,178,000.00 | -25,488,000.00 | 379,952,000.00 | -1,000.00 | 41,806,000.00 | 338,147,000.00 | -16,679,000.00 | 0.00 | -101,208,000.00 | -38,008,000.00 | 122,537,000.00 | 125,153,000.00 | -2,616,000.00 | -28,840,000.00 | -4,000,000.00 | 179,000.00 | -2,000.00 | -2,000.00 | -675,000.00 | 0.00 | -675,000.00 | -24,342,000.00 | 471,000.00 | -24,813,000.00 | 0.00 | 383,666,000.00 | -9,221,000.00 | -98,132,000.00 | 257,929,000.00 | -3,926,000.00 | -150,461,000.00 | 124,962,000.00 | -326,636,000.00 | 101,235,000.00 | 1,172,000.00 | 30,123,000.00 | 16,409,000.00 | 13,714,000.00 | -3,164,000.00 | 12,000.00 | 361,643,000.00 |
| 2022-03-31T00:00:00 | annual | 159,311,000.00 | -11,166,000.00 | 41,806,000.00 | -14,000.00 | 292,161,000.00 | -250,355,000.00 | -222,320,000.00 | 240,000.00 | -106,110,000.00 | -38,008,000.00 | -78,202,000.00 | -78,322,000.00 | 120,000.00 | -198,512,000.00 | -199,000,000.00 | 10,926,000.00 | -3,000.00 | -3,000.00 | -130,000.00 | 0.00 | -130,000.00 | -10,305,000.00 | 731,000.00 | -11,036,000.00 | 0.00 | 170,477,000.00 | -28,774,000.00 | -189,270,000.00 | 125,535,000.00 | -2,193,000.00 | 199,922,000.00 | 59,571,000.00 | -572,105,000.00 | 93,477,000.00 | 892,317,000.00 | 30,841,000.00 | 16,055,000.00 | 14,786,000.00 | 6,259,000.00 | -36,000.00 | -634,337,000.00 |
| 2021-03-31T00:00:00 | annual | -104,855,000.00 | -115,984,000.00 | 292,161,000.00 | -1,000.00 | 219,848,000.00 | 72,314,000.00 | 164,007,000.00 | -1.00 | -88,194,000.00 | 0.00 | 252,201,000.00 | 248,668,000.00 | 3,533,000.00 | -102,822,000.00 | 1.00 | 12,136,000.00 | -502,000.00 | -502,000.00 | -516,000.00 | 0.00 | -516,000.00 | -113,940,000.00 | 1,528,000.00 | -115,468,000.00 | 0.00 | 11,129,000.00 | -3,038,000.00 | -651,279,000.00 | 18,508,000.00 | 8,108,000.00 | -229,729,000.00 | -219,918,000.00 | -228,248,000.00 | 76,058,000.00 | -3,367,000.00 | 28,159,000.00 | 0.00 | 28,159,000.00 | -2,872,000.00 | -41,000.00 | 567,511,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4,645,253.00 | 0.00 | 0.00 | 0.00 | 0.00 | -42,376,973.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: NATHBIOGEN Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Net Income Including Noncontrolling Interests | Net Income Extraordinary | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Write Off | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Research And Development | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 0.15 | 0.00 | 50.03 | 3.43 | 3.43 | 39.62 | 3.26 | 113.57 | 53.45 | 50.19 | -8.88 | 8.63 | 0.32 | 36.34 | 39.62 | 285.89 | 10.59 | 1.90 | 1.90 | 0.00 | 0.00 | 39.62 | 39.62 | 0.00 | 39.62 | 39.62 | 3.45 | 39.62 | 1.95 | 41.56 | 0.30 | 3.43 | -3.45 | 0.02 | -8.88 | 0.58 | 8.63 | 0.32 | 46.74 | 172.32 | 91.15 | 3.26 | 1.61 | 1.66 | 11.28 | 34.92 | 27.64 | 7.29 | 3.46 | 219.05 | 113.57 | 332.62 | 332.62 |
| 2023-03-31T00:00:00 | annual | 0.00 | 0.00 | 48.80 | -0.05 | -0.05 | 35.01 | 3.01 | 114.61 | 48.75 | 45.74 | -10.34 | 9.57 | 0.02 | 35.06 | 35.01 | 255.33 | 9.47 | 1.90 | 1.90 | 0.00 | 0.00 | 35.01 | 35.01 | 0.00 | 35.01 | 35.01 | 0.00 | 35.01 | 1.15 | 36.16 | 0.10 | -0.05 | 0.00 | 0.06 | -10.34 | 0.79 | 9.57 | 0.02 | 46.04 | 140.72 | 72.34 | 3.01 | 1.64 | 1.37 | 9.37 | 29.09 | 23.41 | 5.68 | 3.10 | 186.75 | 114.61 | 301.36 | 301.36 |
| 2022-03-31T00:00:00 | annual | -26.59 | 0.00 | 38.42 | -88.65 | -88.65 | -67.39 | 3.08 | 123.97 | -50.22 | -53.31 | -9.55 | 10.13 | 1.09 | -5.33 | -67.39 | 243.75 | 11.44 | 1.90 | 1.90 | 0.00 | 0.00 | -67.39 | -67.39 | 0.00 | -67.39 | -67.39 | 0.00 | -67.39 | 3.95 | -63.43 | 0.10 | -88.65 | 88.64 | 0.01 | -9.55 | 0.52 | 10.13 | 1.09 | 34.61 | 119.78 | 53.04 | 3.08 | 1.61 | 1.48 | 8.89 | 26.46 | 19.81 | 6.65 | 3.03 | 154.39 | 123.97 | 278.36 | 278.36 |
| 2021-03-31T00:00:00 | annual | 0.00 | 0.00 | 67.48 | -0.01 | -0.01 | 55.66 | 2.82 | 136.10 | 67.47 | 64.65 | -7.65 | 7.90 | 1.21 | 55.67 | 55.66 | 242.88 | 15.12 | 1.90 | 1.90 | 0.00 | 0.00 | 55.66 | 55.66 | 0.00 | 55.66 | 55.66 | 0.00 | 55.66 | 1.09 | 56.75 | 0.07 | -0.01 | -0.07 | 0.08 | -7.65 | 0.96 | 7.90 | 1.21 | 64.46 | 106.79 | 41.48 | 2.82 | 1.60 | 2.82 | 9.15 | 26.29 | 21.20 | 5.09 | 3.08 | 171.25 | 136.10 | 307.34 | 307.34 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
20.58
P/E
9.426142
P/B
0.6364314
Dividend Yield
1.05%
Market Cap
372.50 Cr.
Face Value
304.809
Book Value
304.809
ROE
11.22%
EBITDA Growth
49.56 Cr.
Debt/Equity
19.913
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of nathbiogen?
The market capitalization of Nath Bio-Genes (India) Limited is ₹372 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Nath Bio-Genes (India) Limited?
The PE and PB ratios of Nath Bio-Genes (India) Limited are Not Available and 0.6364314 respectively as of 05 Feb 2025.
What is the 52 Week High of Nath Bio-Genes (India) Limited?
The 52-week high of Nath Bio-Genes (India) Limited is ₹264.31 as of 05 Feb 2025.
What is the 52 Week Low of Nath Bio-Genes (India) Limited?
The 52-week low of Nath Bio-Genes (India) Limited is ₹167.15 as of 05 Feb 2025.
What are the earnings per share (EPS) for Nath Bio-Genes (India) Limited?
The Earnings Per Share (EPS) of Nath Bio-Genes (India) Limited is ₹20.58 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Nath Bio-Genes (India) Limited?
The Return on Equity (ROE) of Nath Bio-Genes (India) Limited is 11.22% as per the most recent financial year data. Explore more on Fincept.